This episode of #ExpertAnswers features Dr. Marcela Maus, Director of Cellular Immunotherapy at Mass General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Maus recently joined us for a webinar about engineering T cells for cancer where she discussed the components and technologies used in making a T cell product, important factors that contribute to their efficacy, and underlying mechanisms of toxicity and resistance.
For more information or to watch the webinar, click here.